Hess Shmuel, Krivoy Amir, Bar-Zeev Yael, Faerman Afik
Lev-Hasharon Medical Center, Pardesiya, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Harefuah. 2021 Feb;160(2):98-103.
Tobacco smoking is the worldwide leading preventable cause of morbidity [1]. The prevalence of current smoking among individuals with mental illnesses is more than twice as that of the general population [2]. Despite it being a primary cause of morbidity and mortality in Israel too, there is little information and research on the features of smoking among people with mental illnesses in Israel.
To present an up-to-date estimation of the prevalence of smoking among hospitalized patients with mental illness in Israel and to compare the prevalence of comorbidities among smokers and non-smokers in this population.
Analyzing data obtained from an electronic medical-records database, consisting of 4646 patients with mental illness, aged 18-90 years, who were hospitalized at Geha Mental Health Center during 2005-2013.
The smoking rate among hospitalized patients with mental illness was significantly higher than the general population (51.3% versus 19.7%, respectively). The smoking rate among male hospitalized patients with mental illness was higher than that of the females (58.2% versus 42.7%, respectively), however, the difference between men and women is smaller compared to this difference in the general population. Smoking rates were highest among those with personality disorder (65.1%), bipolar disorder (58.8%) and schizophrenia (53.81%). The prevalence of comorbid substance use (alcohol or drug abuse) among hospitalized patients with mental illness was found to be higher in the smokers group than in the non-smokers group (37.4% versus 4.6%, respectively, p<0.0001).
The prevalence of smoking among hospitalized patients with mental illness in Israel is 2.74 times that of the general population in 2013, in line with the reported worldwide rate. In addition, among hospitalized patients with mental illness the prevalence of comorbid substance use (alcohol or drug abuse) was higher among the smokers than among the non-smokers.
吸烟是全球首要的可预防发病原因[1]。患有精神疾病的个体中当前吸烟者的比例是普通人群的两倍多[2]。尽管在以色列吸烟也是发病和死亡的主要原因，但关于以色列患有精神疾病者的吸烟特征的信息和研究却很少。
提供以色列住院精神疾病患者吸烟率的最新估计，并比较该人群中吸烟者和非吸烟者共病的患病率。
分析从电子病历数据库中获取的数据，该数据库包含2005年至2013年期间在盖哈心理健康中心住院的4646名18至90岁的精神疾病患者。
住院精神疾病患者的吸烟率显著高于普通人群（分别为51.3%和19.7%）。男性住院精神疾病患者的吸烟率高于女性（分别为58.2%和42.7%），然而，与普通人群中的这种差异相比，男性和女性之间的差异较小。人格障碍患者（65.1%）、双相情感障碍患者（58.8%）和精神分裂症患者（53.81%）的吸烟率最高。发现住院精神疾病患者中吸烟者组共病物质使用（酒精或药物滥用）的患病率高于非吸烟者组（分别为37.4%和4.6%，p<0.0001）。
2013年以色列住院精神疾病患者的吸烟率是普通人群的2.74倍，与全球报道的比率一致。此外，在住院精神疾病患者中，吸烟者中共病物质使用（酒精或药物滥用）的患病率高于非吸烟者。
